FDA Approves OMEPRAZOLE — Quallent Pharmaceuticals Health LLC

Quallent Pharmaceuticals Health LLC announced today the approval of its ANDA075576 application for the oral omeprazole tablets, fulfilling a significant unmet need in the market for the widely used GI drug. This approval positions Quallent to compete directly with branded powerhouses by providing a generic alternative that may drive volume growth within the established proton pump inhibitor sector.